OptiChroniX

Schönenbuch, Switzerland

Alzheimer(s) Disease Patient Education PharmaTech Wearables

OptiChroniX is an American-Swiss Digital Therapeutics company dedicated to improve Brain Health for Millions.We support a healthy brain by focussing on modifiable factors in ones lifestyle and current health status as early as people in their mid forties.OptiChroniX develops a prescribed digital therapeutic (pDTX), a digital solution at the intersection of biomedical, behavioural, computing and engineering research, deployed on smartphones to personalize, track and improve a patient’s health by collecting data from other wearables and nearables. The informed choices offered aim to provide tailored coaching in order to improve health literacy and medication adherence, and to positively impact modifiable factors primarily responsible for the cognitive decline in patients affected by Alzheimer’s disease and associated co-morbidities.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out OptiChroniX on @MedStartr Today #BrainHealth #CognitiveHealth #Wellness #AlzheimerSDisease #PatientEducation #PharmaTech #Wearables #MedMo #MedStartrVentures

https://www.medstartr.ai/s/DTyqEJfNMqE

Get Involved in OptiChroniX

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2020
Website: optichronix.com/

Disease Areas

Brain Health Cognitive Health Wellness

Technologies

Digital TherapeuticsBehavioral Science

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of OptiChroniX?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.